Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Neuromuscular
When do you utilize rozanolixizumab in patients with myasthenia gravis?
Related Questions
How do you counsel patients with mild congenital myopathy about exercise limitations?
How are you counseling your patients with ALS taking sodium phenylbutyrate and taurursodiol on continuing treatment in light of the negative phase 3 trial results?
How do you approach patients with positive LRP4 antibodies without clinical findings of myasthenia gravis?
To what extent do you incorporate electrodiagnostic testing and ultrasonography in your clinical practice for evaluating suspected cases of meralgia paresthetica?
In which clinical scenarios do you find medial and lateral plantar sensory or mixed nerve conduction studies to be valuable?
What testing do you order for patients with suspected dysautonomia?
How do you track objective clinical response to treatment in CIDP?
How do you counsel patients who wish to travel to high altitudes with myasthenia gravis?
What leads you to suspect that a foot drop is secondary to a myopathy rather than a neuropathic process?
Do you perform EMG and repetitive nerve stimulation in patients with ocular myasthenia gravis, particularly those who are AChR-positive, to assess for electrophysiological evidence of generalized disease?
